Drug Type Small molecule drug |
Synonyms DMP 777, L 694458, L-694458 |
Target |
Action inhibitors |
Mechanism ELA2 inhibitors(Leukocyte elastase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC31H40N4O6 |
InChIKeyZSDCIRYNTCVTMF-GIGWZHCTSA-N |
CAS Registry157341-41-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cystic Fibrosis | Phase 2 | United States | - | |
Cystic Fibrosis | Phase 2 | - | - | |
Juvenile Idiopathic Arthritis | Phase 2 | United States | - | |
Juvenile Idiopathic Arthritis | Phase 2 | - | - | |
Pulmonary Emphysema | Phase 1 | United States | - |